Q&A with Union Jack Oil: Oil and gas at West Newton (LON:UJO)
3 September 2019
Belite Bio, Inc (NASDAQ: BLTE) has become a notable player in the biotechnology sector, intriguing investors with its promising pipeline and a potential upside of 14.88%. Based in San Diego,..
Sotera Health Company (NASDAQ: SHC) stands as a prominent player within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $4.52 billion, Sotera Health..
Immunovant, Inc. (NASDAQ: IMVT) continues to capture the attention of investors, particularly those with an eye for emerging opportunities in the healthcare sector. As a clinical-stage biotechnology company, Immunovant focuses..
Envista Holdings Corporation (NYSE: NVST) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista specializes in developing, manufacturing,..
Perrigo Company plc (NYSE: PRGO) stands out in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry, with a market capitalization of $1.7 billion. Headquartered in..
Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector specializing in medical devices, is making waves with its innovative solutions for obstructive sleep apnea (OSA). As..
Regencell Bioscience Holdings Limited (NASDAQ: RGC) presents a unique investment opportunity with its distinct focus on Traditional Chinese Medicine (TCM) for neurocognitive disorders. Based in Hong Kong, this specialty drug..
Teleflex Incorporated (NYSE: TFX), a dominant player in the healthcare sector, specializes in the design, development, and manufacture of single-use medical devices used in critical care and surgical applications. With..
Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 46.52% based on current analyst projections. Known for its focus..
Telix Pharmaceuticals Limited (ASX: TLX), a prominent player in the biopharmaceutical landscape, presents a compelling opportunity for investors with its innovative approach to developing therapeutic and diagnostic radiopharmaceuticals. Despite its..
Atrium Therapeutics, Inc. (RNA) presents a compelling narrative in the biotech sector, driven by its innovative approach to RNA therapeutics aimed at transforming cardiac care. With a market capitalization of..
Legend Biotech Corporation (NASDAQ: LEGN) stands out in the biotechnology sector, not only for its innovative advancements in cell therapy but also for its striking potential upside of 208.93%, as..
DaVita Inc. (DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is making waves with its impressive return on equity (ROE) of 64.85%. This..
Krystal Biotech, Inc. (NASDAQ: KRYS) is a burgeoning player in the biotechnology sector, making significant strides in the genetic medicine landscape. With a market cap of $8.06 billion, this Pittsburgh-based..
Glaukos Corporation (NYSE: GKOS), a notable player in the healthcare sector, specifically within the medical devices industry, is capturing investor attention with its innovative therapies targeting ophthalmic conditions. With a..
Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to make strides in the competitive landscape of oncology treatment. With a focus on developing and commercializing novel..
TransMedics Group, Inc. (Nasdaq: TMDX) is rapidly gaining attention in the healthcare sector, specifically in the medical devices industry. The company is revolutionizing organ transplant therapy with its innovative Organ..
Oscar Health, Inc. (OSCR), a healthcare technology company headquartered in New York, is garnering attention from investors due to its innovative approach to healthcare plans and its intriguing potential for..
BeOne Medicines Ltd. (ONC), a Swiss-based biotech powerhouse, is capturing investors’ attention with its robust oncology-focused pipeline and impressive revenue growth. With a market capitalization of $35.08 billion, this healthcare..
